Greater Occipital Nerve Injection versus Oral Steroids for Short Term Prophylaxis of Cluster Headache: A Retrospective Comparative Study

2018 ◽  
Vol 58 (6) ◽  
pp. 852-858 ◽  
Author(s):  
Jerry Wei ◽  
Matthew S. Robbins
Keyword(s):  
Cluster Headache ◽  
Comparative Study ◽  
Short Term ◽  
Occipital Nerve ◽  
Greater Occipital Nerve ◽  
Oral Steroids ◽  
Retrospective Comparative Study ◽  
Short Term Prophylaxis

Efficacy and safety of 121 injections of the greater occipital nerve in episodic and chronic cluster headache

Cephalalgia ◽  
2012 ◽  
Vol 32 (8) ◽  
pp. 630-634 ◽  
Author(s):  
Andreas R Gantenbein ◽  
Nina J Lutz ◽  
Franz Riederer ◽  
Peter S Sándor
Keyword(s):  
Cluster Headache ◽  
Chronic Cluster Headache ◽  
Efficacy And Safety ◽  
Occipital Nerve ◽  
Greater Occipital Nerve

scholarly journals Occipital neuroma triggered cluster headache responding to greater occipital nerve blockade

2008 ◽  
Vol 66 (1) ◽  
pp. 74-76 ◽  
Author(s):  
Fabrizio Di Stani ◽  
Elcio Juliato Piovesan ◽  
Lorena Scattoni ◽  
Gianluca Bruti ◽  
Lineu Cesar Werneck
Keyword(s):  
Cluster Headache ◽  
Nerve Blockade ◽  
Occipital Nerve ◽  
Greater Occipital Nerve

Short-term effects of greater occipital nerve blocks in chronic migraine: A double-blind, randomised, placebo-controlled clinical trial

Cephalalgia ◽  
2016 ◽  
Vol 37 (9) ◽  
pp. 864-872 ◽  
Author(s):  
María L Cuadrado ◽  
Ángel Aledo-Serrano ◽  
Patricia Navarro ◽  
Pedro López-Ruiz ◽  
César Fernández-de-las-Peñas ◽  
...  
Keyword(s):  
Clinical Trial ◽  
Chronic Migraine ◽  
Severe Headache ◽  
Controlled Clinical Trial ◽  
Short Term ◽  
Double Blind ◽  
Occipital Nerve ◽  
Anaesthetic Block ◽  
Pressure Pain Thresholds ◽  
Greater Occipital Nerve

Background Greater occipital nerve (GON) blocks are widely used for the treatment of headaches, but quality evidence regarding their efficacy is scarce. Objective The objective of this article is to assess the short-term clinical efficacy of GON anaesthetic blocks in chronic migraine (CM) and to analyse their effect on pressure pain thresholds (PPTs) in different territories. Participants and methods The study was designed as a double-blind, randomised, placebo-controlled clinical trial. Thirty-six women with CM were treated either with bilateral GON block with bupivacaine 0.5% ( n = 18) or a sham procedure with normal saline ( n = 18). Headache frequency was recorded a week after and before the procedure. PPT was measured in cephalic points (supraorbital, infraorbital and mental nerves) and extracephalic points (hand, leg) just before the injection (T0), one hour later (T1) and one week later (T2). Results Anaesthetic block was superior to placebo in reducing the number of days per week with moderate-or-severe headache (MANOVA; p = 0.027), or any headache ( p = 0.04). Overall, PPTs increased after anaesthetic block and decreased after placebo; after the intervention, PPT differences between baseline and T1/T2 among groups were statistically significant for the supraorbital (T0–T1, p = 0.022; T0–T2, p = 0.031) and infraorbital sites (T0–T1, p = 0.013; T0–T2, p = 0.005). Conclusions GON anaesthetic blocks appear to be effective in the short term in CM, as measured by a reduction in the number of days with moderate-to-severe headache or any headache during the week following injection. GON block is followed by an increase in PPTs in the trigeminal area, suggesting an effect on central sensitisation at the trigeminal nucleus caudalis. This trial is registered at ClinicalTrials.gov (NCT02188394).

Sign in / Sign up

Export Citation Format

Share Document